Effects of drugs on cholesterol esterification in normal and Niemann-Pick type C fibroblasts: AY-9944, other cationic amphiphilic drugs and DMSO
- 31 March 1991
- journal article
- Published by Elsevier in Brain & Development
- Vol. 13 (2) , 115-120
- https://doi.org/10.1016/s0387-7604(12)80118-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Abnormal cholesterol metabolism in imipramine-treated fibroblast cultures. Similarities with Niemann-Pick type C diseaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Type C Niemann-Pick disease: dimethyl sulfoxide moderates abnormal LDL-cholesterol processing in mutant fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Correction of sphingomyelinase deficiency in Niemann‐Pick type C fibroblasts by removal of lipoprotein fraction from culture mediaJournal of Inherited Metabolic Disease, 1988
- Effects of dimethylsulfoxide on sphingomyelinase activities in normal and Niemann-Pick type A, B and C fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Therapeutic Effects of Dipolar Aprotic Substances on Niemann‐Pick CellsPediatrics International, 1987
- A defect in cholesterol esterification in Niemann-Pick disease (type C) patients.Proceedings of the National Academy of Sciences, 1985
- STRUCTURAL BASIS FOR BIOLOGICAL ACTIVITIES OF DIMETHYL SULFOXIDE*Annals of the New York Academy of Sciences, 1983
- Inhibition of human fibroblasts sphingomyelinase by cholesterol and 7-dehydrocholesterolBiochemical and Biophysical Research Communications, 1981
- Lipid and lysosomal enzymes in human fibroblasts cultured with perhexiline maleateNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
- Niemann-Pick Disease Experimental Model: Sphingomyelinase Reduction Induced by AY-9944Science, 1977